reports
Applied Materials to Participate in Upcoming Investor Conferences
Applied Materials to Participate in Upcoming Investor Conferences SANTA CLARA, Calif., May 17, 2024 (GLOBE NEWSWIRE) -- Applied Materials, Inc. today announced that Gary Dickerson, President and CEO, and Brice Hill, Senior Vice President and CFO, will participate in fireside chats at upcoming investor conferences. Mr. Dickerson will participate at the Bernstein Strategic Decisions Conference in New York on Thursday, May 30 beginning at 11:30 a.m. PT / 2:30 p.m. ET. Mr. Hill will participate at the BofA Securities Global Technology Conference in San Francisco on Thursday, June 6 beginnin...
Cantourage Group SE: 1 director
A director at Cantourage Group SE sold 20,144 shares at 7.004EUR and the significance rating of the trade was 61/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clea...
- ABGSC Capital Goods Research
- Karl Bokvist
Partners Value Investments L.P. Announces Q1 2024 Interim Results
Partners Value Investments L.P. Announces Q1 2024 Interim Results TORONTO, May 17, 2024 (GLOBE NEWSWIRE) -- Partners Value Investments L.P. (the “Partnership”, TSX: PVF.UN TSX:PVF.PR.U) announced today its financial results for the three months ended March 31, 2024. All amounts are stated in U.S. dollars. The Partnership recorded net income of $26.3 million for the three months ended March 31, 2024, compared to net income of $7.3 million in the prior year quarter. The increase in income was primarily driven by the higher dividend income, foreign currency gains and tax recoveries. I...
Cytokinetics Hosts Muscle Biology-Focused Research Symposium: Contempo...
Cytokinetics Hosts Muscle Biology-Focused Research Symposium: Contemporary Landscapes in Muscle Biology SOUTH SAN FRANCISCO, Calif., May 17, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) announced that the Company will host the muscle biology-focused Contemporary Landscapes in Muscle Biology Research Symposium (CLIMB) today, May 17th, 2024 at the Mission Bay Conference Center in San Francisco. “We are proud to convene the CLIMB Research Symposium, a unique forum for the muscle biology community, including academic researchers and students, to engage in scientific di...
GameStop Announces First Quarter Preliminary Results
GameStop Announces First Quarter Preliminary Results GRAPEVINE, Texas, May 17, 2024 (GLOBE NEWSWIRE) -- GameStop Corp. (NYSE: GME) (“GameStop” or the “Company”) today announced certain preliminary unaudited financial information for the first quarter ended May 4, 2024. On a preliminary basis for the 13-weeks ended May 4, 2024 compared to the 13-weeks ended April 29, 2023: Net sales are expected to be in the range of $0.872 billion to $0.892 billion compared to $1.237 billion in the prior year fiscal quarter.Selling, general and administrative (“SG&A") expenses are expected to be in ...
Hardman & Co Research on Volta Finance Limited: Putting the discount i...
Hardman & Co Research Hardman & Co Research on Volta Finance Limited: Putting the discount into perspective 17-May-2024 / 12:15 GMT/BST The issuer is solely responsible for the content of this announcement. Hardman & Co Research | Closed End Investments Volta Finance Limited (VTAS) | Putting the discount into perspective Volta’s share price discount to NAV (26%) is now back to the levels seen in the early stages of the pandemic. This appears anomalous with 6.3% total shareholder return in 1Q’24, the annualised cashflows in excess of 20%, the consensus outlook, as well as the...
Gamma Communications: 1 director
A director at Gamma Communications sold 5,000 shares at 1,451p and the significance rating of the trade was 56/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearl...
ChemoMetec A S: 2 directors
A director at ChemoMetec A S bought 1,427 shares at 348.960DKK and the significance rating of the trade was 71/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearl...
Sjm Holdings Limited: 1 director
A director at Sjm Holdings Limited bought 8,827,000 shares at 2.997HKD and the significance rating of the trade was 80/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...
Telix Files Registration Statement for Proposed Initial Public Offerin...
Telix Files Registration Statement for Proposed Initial Public Offering in the United States MELBOURNE, Australia, May 17, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has filed a registration statement on Form F-1 (Registration Statement) with the United States (U.S.) Securities and Exchange Commission (SEC) today (U.S. time) relating to a proposed initial public offering (Offering) of its American Depository Shares (ADSs), representing the Company’s ordinary shares, in the U.S. Telix has applied to list the ADSs on the Nas...
Brenntag SE: 1 director
A director at Brenntag SE bought 700 shares at 71.277EUR and the significance rating of the trade was 55/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...
DSV, 1110 - MAJOR SHAREHOLDER ANNOUNCEMENT
DSV, 1110 - MAJOR SHAREHOLDER ANNOUNCEMENT Company Announcement No. 1110 Pursuant to section 30 of the Danish Capital Markets Act it is announced that BlackRock, Inc. has informed DSV A/S that the total shares according to section 38 of the Danish Capital Markets Act, and other financial instruments according to section 39(2) of the Danish Capital Markets Act of DSV A/S held by BlackRock, Inc. as of 14 May 2024 correspond to below 5% of the entire share capital and below 5% of the voting rights of DSV A/S. ContactsInvestor Relations: Sebastian Rosborg, tel. , Yours sincerely,DSV ...
Lonking Holdings Ltd: 1 director
A director at Lonking Holdings Ltd sold 1,714,000 shares at 1.713HKD and the significance rating of the trade was 51/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years ...
Alliance Entertainment Holding Corp: 2 directors
Two Directors at Alliance Entertainment Holding Corp bought 23,000 shares at between 2.540USD and 2.550USD. The significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's...
Marinus Pharmaceuticals Announces Key Business Updates for Tuberous Sc...
RADNOR, Pa.--(BUSINESS WIRE)-- , Inc. (Nasdaq:MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced completion of enrollment in the global Phase 3 TrustTSC trial evaluating oral ganaxolone for the treatment of seizures associated with tuberous sclerosis complex (TSC) in children and adults. “We are pleased to announce we have completed enrollment in our pivotal Phase 3 trial in tuberous sclerosis complex,” said Alex Aimetti, Ph.D., Chief Scientific Officer at Marinus Pharmaceuticals. “The TrustTSC study enrolled hi...
NFI subsidiary New Flyer announces contract with BC Transit for 33 bat...
NFI subsidiary New Flyer announces contract with BC Transit for 33 battery-electric buses WINNIPEG, Manitoba, May 17, 2024 (GLOBE NEWSWIRE) -- (TSX: NFI, OTC: NFYEF, TSX: NFI.DB) New Flyer Industries Canada ULC (New Flyer), a subsidiary of NFI Group Inc. (NFI) and leading manufacturer of heavy-duty transit buses, today announced a contract with BC Transit Corporation (BC Transit) for 33 next-generation Xcelsior CHARGE NG™ 40-foot battery-electric buses (BEBs). The contract was added to New Flyer’s firm backlog in 2024 Q2. BC Transit oversees municipal transit services for over 130 ...
Exchange Income Corporation Announces May 2024 Dividend
WINNIPEG, Manitoba--(BUSINESS WIRE)-- Exchange Income Corporation (TSX: EIF) (the “Corporation”), a diversified, acquisition-oriented company focused on opportunities in the aerospace & aviation and manufacturing segments, announced today that the Directors of the Corporation have declared eligible dividends totaling $0.22 per share for the month ended May 31, 2024 payable June 14, 2024 to shareholders of record at the close of business on May 31, 2024. Eligible shareholders have the opportunity to reinvest their dividends in accordance with the Corporation’s dividend reinvestment and share ...
Psyence Biomed to Participate in the A.G.P. Virtual Healthcare Company...
Psyence Biomed to Participate in the A.G.P. Virtual Healthcare Company Showcase NEW YORK, May 17, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd (Nasdaq:PBM) (“Psyence Biomed” or the “Company”) today announced that management will host 1x1 meetings with investors during the A.G.P. Virtual Healthcare Company Showcase, which is being held May 21, 2024. For more information, or to register: . About Psyence Biomed Psyence Biomedical Ltd., a corporation organized under the laws of Ontario, Canada, is the world’s first life science biotechnology company traded on The Nasdaq Stock Market LLC...
Virtu Financial Congratulates Michelle Hosea, Recipient of the Rising ...
Virtu Financial Congratulates Michelle Hosea, Recipient of the Rising Star Award at Women in Finance Asia Awards NEW YORK, May 17, 2024 (GLOBE NEWSWIRE) -- Virtu Financial, Inc. (Nasdaq:VIRT), a leading provider of global, multi-asset financial services that delivers liquidity and innovative, transparent products across the complete investment cycle to the global markets, is pleased to congratulate Michelle Hosea, Quantitative Strategist, on her Women in Finance Asia 2024 Rising Star Award. In Michelle’s three years at Virtu, she has quickly taken a leadership role on the quantitative ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.